Editas Medicine, Inc. Common Stock
$3.550
USD
Last updated on --.
24h volume16.90M
24h highest3.9400 USD
24h lowest3.2200 USD
24h Price movement+15.26%
EDIT recent prices
24 Hours
+15.26%+$0.47
30 days
+19.12%+$0.585
60 days
+63.45%+$1.415
90 days
+65.68%+$1.445
Key data
Previous close3.0800 USD
Market cap254.56M USD
Volume16.90M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-1.1100 USD
Net income (FY)-108.95M USD
Revenue (FY)38.69M USD
Last report dateMay 5, 2026
About Editas Medicine, Inc. Common Stock
HeadquartersCAMBRIDGE
Employees (FY)87.00
Revenue per employee (FY)444.75K USD
Net income per employee (FY)-1.25M USD
Listed onNasdaq
EDIT conversion tables
 |  |
|---|---|
| 0.5 EDIT | 1.775 USD |
| 1 EDIT | 3.550 USD |
| 5 EDIT | 17.75 USD |
| 10 EDIT | 35.5 USD |
| |
|---|---|
| 0.5 USD | 0.14085 EDIT |
| 1 USD | 0.28169 EDIT |
| 5 USD | 1.408 EDIT |
| 10 USD | 2.816 EDIT |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
EDIT is trading at $3.550, +15.26% over the last 24 hours. Track live moves on the price chart at the top of this page.
The EDIT stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. EDIT is currently trading at $3.550, +15.26% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on EDIT price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. EDIT's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from EDIT; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against EDIT's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Editas Medicine, Inc. Common Stock's market cap is currently 254.56M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume16.90M
24h highest3.9400 USD
24h lowest3.2200 USD
24h Price movement+15.26%
Start trade with EDIT Perpetual
Sign up to trade